Cargando…
Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report
BACKGROUND: An extremely rare condition, radiation-induced angiosarcoma is characterized by a poor prognosis, high recurrence rate and lack of effective treatment. Herein, we present a case report of a 48-year-old female patient with radiation-induced abdominal wall angiosarcoma who showed a dramati...
Autores principales: | Guan, Jieshan, Luo, Zhijie, Xiao, Zhiwei, Xie, Yubin, Lin, Lizhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896664/ https://www.ncbi.nlm.nih.gov/pubmed/31805975 http://dx.doi.org/10.1186/s12885-019-6351-4 |
Ejemplares similares
-
Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report
por: Yang, Lishu, et al.
Publicado: (2018) -
Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma
por: Kurisetty, Vittal, et al.
Publicado: (2013) -
MYC Amplification in Angiosarcoma Arising from an Arteriovenous Graft Site
por: Paral, Kristen M., et al.
Publicado: (2015) -
Successful treatment of angiosarcoma of the scalp with apatinib: a case report
por: Ji, Guanghui, et al.
Publicado: (2016) -
HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes
por: Boikova, Aleksandra, et al.
Publicado: (2022)